NASDAQ:LFMD - LifeMD Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $15.50
  • Forecasted Upside: 265.57 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$4.24
▼ -0.04 (-0.93%)

This chart shows the closing price for LFMD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New LifeMD Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LFMD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LFMD

Analyst Price Target is $15.50
▲ +265.57% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for LifeMD in the last 3 months. The average price target is $15.50, with a high forecast of $16.00 and a low forecast of $15.00. The average price target represents a 265.57% upside from the last price of $4.24.

This chart shows the closing price for LFMD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 polled investment analysts is to buy stock in LifeMD.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/1/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/30/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/28/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/27/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/11/2021BTIG ResearchLower Price TargetBuy$30.00 ➝ $15.00High
10/4/2021B. RileyReiterated RatingBuy$16.00Medium
8/13/2021BTIG ResearchLower Price TargetBuy$35.00 ➝ $30.00High
7/19/2021BTIG ResearchLower Price TargetPositive ➝ Buy$43.00 ➝ $35.00Medium
6/8/2021BTIG ResearchReiterated RatingBuy$40.00High
(Data available from 11/27/2016 forward)

News Sentiment Rating

0.65 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/1/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/31/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/30/2021
  • 2 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
7/30/2021
  • 5 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
8/29/2021
  • 1 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/28/2021
  • 6 very positive mentions
  • 14 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/28/2021
  • 4 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/27/2021

Current Sentiment

  • 4 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
LifeMD logo
LifeMD, Inc. is a telehealth company, which engages in offering portfolio of direct-to-patient products and services. It combines virtual medical treatment with prescription medications and over-the-counter products. The firm's network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the United States. The company's brands include Shapiro, Rex, and Nava. LifeMD was founded in 1987 and is headquartered in New York, NY.
Read More

Today's Range

Now: $4.24
Low: $4.12
High: $4.37

50 Day Range

MA: $5.72
Low: $4.10
High: $7.52

52 Week Range

Now: $4.24
Low: $3.95
High: $33.02

Volume

185,774 shs

Average Volume

880,867 shs

Market Capitalization

$129.71 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63

Frequently Asked Questions

What sell-side analysts currently cover shares of LifeMD?

The following sell-side analysts have issued reports on LifeMD in the last year: B. Riley, BTIG Research, and Zacks Investment Research.
View the latest analyst ratings for LFMD.

What is the current price target for LifeMD?

2 Wall Street analysts have set twelve-month price targets for LifeMD in the last year. Their average twelve-month price target is $15.50, suggesting a possible upside of 262.1%. B. Riley has the highest price target set, predicting LFMD will reach $16.00 in the next twelve months. BTIG Research has the lowest price target set, forecasting a price of $15.00 for LifeMD in the next year.
View the latest price targets for LFMD.

What is the current consensus analyst rating for LifeMD?

LifeMD currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe LFMD will outperform the market and that investors should add to their positions of LifeMD.
View the latest ratings for LFMD.

How do I contact LifeMD's investor relations team?

LifeMD's physical mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The company's listed phone number is (866) 351-5907 and its investor relations email address is [email protected] The official website for LifeMD is www.lifemd.com.